Quetiapine fumarate cas: 111974-72-2

CAS NO: 111974-72-2
Quetiapine fumarate
Description Review
Description

Quetiapine Fumarate, also known as Seroquel, is an atypical antipsychotic medication used to treat schizophrenia, bipolar disorder, and major depressive disorder. This drug was first approved by the FDA in 1997 and has been widely used for managing psychiatric symptoms.

Chemical Name:

The chemical name of Quetiapine Fumarate is 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate.

Molecular Formula:

The molecular formula of Quetiapine Fumarate is C42H50N6O4S.

Formula Weight:

The formula weight of Quetiapine Fumarate is 883.04 g/mol.

CAS No:

The CAS number of Quetiapine Fumarate is 111974-72-2.

Top Ten Keywords from Google and Synonyms:

  1. Atypical antipsychotic
  2. Schizophrenia treatment
  3. Bipolar disorder medication
  4. Major depressive disorder therapy
  5. Seroquel
  6. Dopamine antagonist
  7. Antipsychotic drug
  8. Mood stabilizer
  9. Psychotic disorder management
  10. Neuroleptic drug

Synonyms: Quetiapine, Quetiapine Hemifumarate, Iodinet, Ketipinor, Kventiax, Seroquel XR, Teva-Quetiapine

Health Benefits of Quetiapine Fumarate:

Quetiapine Fumarate is primarily used to manage the symptoms of schizophrenia, bipolar disorder, and major depressive disorder. It helps in reducing hallucinations, delusions, and other psychotic symptoms associated with these conditions. Additionally, it can help stabilize mood and reduce anxiety in some patients.

Potential Effects:

Quetiapine Fumarate is an atypical antipsychotic that works by blocking the dopamine and serotonin receptors in the brain. By doing so, it changes the balance of chemicals in the brain, which can help reduce the severity of psychotic symptoms. It also has sedative effects, which can help patients sleep better and reduce anxiety.

Product Mechanism:

Quetiapine Fumarate works by blocking the dopamine and serotonin receptors in the brain. These receptors are responsible for the body's response to these neurotransmitters, which play a critical role in regulating mood, behavior, and perception. By blocking these receptors, Quetiapine Fumarate reduces the activity of these neurotransmitters, which can help reduce psychotic symptoms.

Safety:

Quetiapine Fumarate is generally considered safe when used as directed. However, like all medications, it may cause side effects in some people. It is not recommended for certain patients, such as those who have dementia, liver disease, or a history of seizures. It should also be used with caution in people with diabetes, low blood pressure, or heart disease.

Side Effects:

Common side effects of Quetiapine Fumarate include drowsiness, dry mouth, constipation, and blurred vision. Rare but serious side effects may include neuroleptic malignant syndrome, tardive dyskinesia, and metabolic syndrome. Patients who experience any of these symptoms should seek immediate medical attention.

Dosing Information:

The recommended dose of Quetiapine Fumarate depends on the condition being treated and the individual patient's response to the medication. For schizophrenia, the usual starting dose is 25 mg twice daily, which may be increased gradually to a maximum of 800 mg per day. For bipolar disorder and major depressive disorder, the recommended starting dose is 50 mg once daily, which may be increased gradually to a maximum of 300 mg per day.

Conclusion:

Quetiapine Fumarate is an atypical antipsychotic medication used to manage the symptoms of schizophrenia, bipolar disorder, and major depressive disorder. It works by blocking the dopamine and serotonin receptors in the brain, which can help reduce the severity of psychotic symptoms. While it is generally safe and effective, it may cause side effects in some patients and is not recommended for certain populations. If you have any questions about Quetiapine Fumarate or its use, please consult your healthcare provider.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code